Tirzepatide 10mg (Single Vial)

Dual GLP-1/GIP Receptor Agonist | Advanced Injectable for Weight Management & Metabolic Support

Overview:

Tirzepatide is a cutting-edge dual incretin agonist that mimics both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — two key hormones involved in regulating blood sugar, satiety, and energy balance. This unique mechanism allows for enhanced appetite suppression, improved insulin sensitivity, and significant fat loss when combined with proper nutrition and lifestyle protocols.

Available as a lyophilized powder, Tirzepatide requires reconstitution prior to use.

Product Details

Dual GLP-1/GIP Receptor Agonist | Advanced Injectable for Weight Management & Metabolic Support

Overview:

Tirzepatide is a cutting-edge dual incretin agonist that mimics both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — two key hormones involved in regulating blood sugar, satiety, and energy balance. This unique mechanism allows for enhanced appetite suppression, improved insulin sensitivity, and significant fat loss when combined with proper nutrition and lifestyle protocols.

Available as a lyophilized powder, Tirzepatide requires reconstitution prior to use.

Why Choose Tirzepatide 10mg (Single Vial)?

Tirzepatide offers a next-generation approach to weight management by targeting two incretin pathways instead of one.

Its superior appetite control, metabolic efficiency, and once-weekly dosing make it a preferred option for individuals seeking more advanced body composition and metabolic support outcomes.

Key Benefits

Dramatically reduces hunger and cravings

• Promotes significant and sustainable weight loss

• Improves glucose regulation and insulin efficiency

• Once-weekly subcutaneous injection for ease of use

• Supports cardiometabolic health markers (A1C, triglycerides, blood pressure)

Reconstitution Instructions

Reconstitute with Bacteriostatic Water (BAC)

• Example: Add 2mL of BAC to a 10mg vial to yield 5mg/mL

• Gently swirl (do not shake) until fully dissolved

• Store reconstituted Tirzepatide in the refrigerator (2–8°C)

• Use within 28 days

Need help with dosage or reconstitution math?

Typical Dosing Guidelines

Start at 2.5mg weekly, titrate upward gradually

• Therapeutic range: 5mg–15mg per week, depending on goals and tolerance

• Administer subcutaneously in the abdomen, thigh, or upper arm

• Duration of use: 12–24+ weeks based on results and clinical response

Monitoring & Considerations:

• Common side effects: Mild nausea, early satiety, constipation, or fatigue (typically temporary)

• Monitor: Blood sugar, hydration, and gastrointestinal tolerance

• Not suitable for individuals with a personal/family history of medullary thyroid carcinoma (MTC) or MEN2 syndromes

Note